Top Markets
#1 Black Phoenix Black Phoenix +354.71%
#2 Glidr Glidr +84.34%
#3 OpenEden OpenEden +71.47%
#4 Gold Park Gold Park +68.84%
#5 Akedo Akedo +55.26%
#6 BasedHype BasedHype +26.51%
#7 Cryptopia Cryptopia +21.54%
#8 Humanity Humanity +20.22%
#9 Avantis Avantis +19.35%
#10 Ether.fi Ether.fi +17.25%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Synairgen plc Synairgen plc

Synairgen plc

SNG
주식 순위 #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
주가
$0.01292666
마지막 동기화: 2025-04-08
시가총액
$157.54K
변동 (1일)
6.84%
변동 (1년)
0.00%
국가
GB
거래 Synairgen plc (SNG)

카테고리

Healthcare
Synairgen plc (SNG)의 배당 이력
Synairgen plc (주식 심볼: SNG)은 총 0회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): 0.00
배당 수익률 (TTM): 0
Synairgen plc (SNG)의 2026부터 2026까지 배당 지급 내역
연간 배당 지급
연도 배당금 (주식 분할 조정됨) 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
모든 배당 지급 목록
연도 배당금 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 지급
회사 배당 지급 횟수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE